Overview
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- VP, Research & OperationsChristopher Bryan named Apr 10, 2024 to Jun 26, 20263
- Chief Executive OfficerChristopher Moreau named Apr 10, 2024 to Jun 26, 20263
- Chief Financial OfficerJames Kinley named Apr 10, 2024 to Jun 26, 20263
- DirectorHarry Bloomfield named Apr 10, 2024 to Jun 26, 20263
- DirectorHoward Gutman named Apr 10, 2024 to Jun 26, 20263
- DirectorMark Williams named Apr 10, 2024 to Jun 26, 20263
- DirectorRaj Attariwala named Apr 10, 2024 to Jun 26, 20263
Former names
Filings
15 filings to the SEC since October 2021: 4 private raises, 11 other. The latest 15:
- Jun 26, 2026D EDGAR
- Dec 9, 2025D/A EDGAR
- Dec 1, 2025D EDGAR
- Apr 10, 2024D EDGAR
- Dec 21, 2022RW EDGAR
- Jun 3, 2022F-1/A EDGAR
- May 10, 2022FWP EDGAR
- May 9, 2022F-1/A EDGAR
- Apr 25, 2022F-1/A EDGAR
- Apr 15, 2022F-1/A EDGAR
- Apr 6, 2022F-1/A EDGAR
- Mar 24, 2022F-1/A EDGAR
- Feb 22, 2022F-1 EDGAR
- Jan 21, 2022DRS/A EDGAR
- Oct 20, 2021DRS EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $291.1K
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2026 | $28.5K | $28.5K |
| 2025 | $250.0K | $250.0K |
| 2024 | $12.6K | $12.6K |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
SEC filer profile
How Grey Matters Health Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARGrey Matters Health Inc.1
- CIK0001642178
- Incorporated inBritish Columbia, Canada1
- Fiscal year endsAugust 311
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address400 - 601 West Broadway, Vancouver, British Columbia, Canada1
- Phone60439841751
- On EDGAR sinceMay 29, 20151
- Filings19 in all: D (7), F-1/A (6), D/A (1), DRS (1), DRS/A (1), F-1 (1), FWP (1), RW (1)1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5